Skip to content Skip to footer

Search for Research output

5741 - 5750 out of 6,746Page size: 10
Sort by: Relevance
6746 Results for: "SDG 3 – Gute Gesundheit und Wohlergehen"
  1. Published

    Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer

    Folprecht, G., Hamann, S., Schütte, K., Trarbach, T., Stoehlmacher-Williams, J. & Ehninger, G., 19 Jul 2014, In: BMC cancer. 14, 1, 521.

    Research output: Contribution to journal › Research article › Contributed › peer-review

  2. E-pub ahead of print

    Voxel-wise deviations from healthy aging for the detection of region-specific atrophy

    for the Alzheimer's Disease Neuroimaging Initiative & Linn, J., 19 Sept 2018, (E-pub ahead of print) In: NeuroImage: Clinical. 20, p. 851-860 10 p.

    Research output: Contribution to journal › Research article › Contributed › peer-review

  3. Published

    Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial

    German Rectal Cancer Study Group, Feb 2021, In: European journal of cancer. 144, p. 281-290 10 p.

    Research output: Contribution to journal › Research article › Contributed › peer-review

  4. Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A

    Burgermeister, E., Battaglin, F., Eladly, F., Wu, W., Herweck, F., Schulte, N., Betge, J., & 12 othersHärtel, N., Kather, J. N., Weis, C. A., Gaiser, T., Marx, A., Weiss, C., Hofheinz, R., Miller, I. S., Loupakis, F., Lenz, H. J., Byrne, A. T. & Ebert, M. P., Jul 2019, In: EBioMedicine. 45, p. 139-154 16 p.

    Research output: Contribution to journal › Research article › Contributed › peer-review

  5. Published

    Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)

    Folprecht, G., Gruenberger, T., Bechstein, W., Raab, H. R., Weitz, J., Lordick, F., Hartmann, J. T., & 10 othersStoehlmacher-Williams, J., Lang, H., Trarbach, T., Liersch, T., Ockert, D., Jaeger, D., Steger, U., Suedhoff, T., Rentsch, A. & Köhne, C. H., May 2014, In: Annals of oncology. 25, 5, p. 1018-1025 8 p.

    Research output: Contribution to journal › Research article › Contributed › peer-review

  6. Published

    Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE‐3)

    Moehler, M., Folprecht, G., Heinemann, V., Holch, J. W., Maderer, A., Kasper, S., Hegewisch‐Becker, S., & 15 othersSchröder, J., Overkamp, F., Kullmann, F., Bechstein, W. O., Vöhringer, M., Öllinger, R., Lordick, F., Geißler, M., Schulz‐Abelius, A., Linz, B., Bernhard, H., Paul, A., Schmidtmann, I., Potthoff, K. & Schimanski, C. C., 15 Apr 2022, In: International journal of cancer. 150, 8, p. 1341-1349 9 p.

    Research output: Contribution to journal › Research article › Contributed › peer-review

  7. Published

    Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

    Horak, P., Heining, C., Kreutzfeldt, S., Hutter, B., Mock, A., Hüllein, J., Fröhlich, M., & 52 othersUhrig, S., Jahn, A., Rump, A., Gieldon, L., Möhrmann, L., Hanf, D., Teleanu, V., Heilig, C. E., Lipka, D. B., Allgäuer, M., Ruhnke, L., Laßmann, A., Endris, V., Neumann, O., Penzel, R., Beck, K., Richter, D., Winter, U., Wolf, S., Pfütze, K., Geörg, C., Meißburger, B., Buchhalter, I., Augustin, M., Aulitzky, W. E., Hohenberger, P., Kroiss, M., Schirmacher, P., Schlenk, R. F., Keilholz, U., Klauschen, F., Folprecht, G., Bauer, S., Siveke, J. T., Brandts, C. H., Kindler, T., Boerries, M., Illert, A. L., von Bubnoff, N., Jost, P. J., Spiekermann, K., Bitzer, M., Schulze-Osthoff, K., von Kalle, C., Klink, B., Brors, B., Stenzinger, A., Schröck, E., Hübschmann, D., Weichert, W., Glimm, H. & Fröhling, S., Nov 2021, In: Cancer discovery. 11, 11, p. 2780-2795 16 p.

    Research output: Contribution to journal › Research article › Contributed › peer-review

  8. Published

    Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates

    Hauser, S., Sommerfeld, P., Wodtke, J., Hauser, C., Schlitterlau, P., Pietzsch, J., Löser, R., & 2 othersPietsch, M. & Wodtke, R., 1 May 2022, In: International journal of molecular sciences. 23, 9, 4475.

    Research output: Contribution to journal › Research article › Contributed › peer-review

  9. Published

    Novel Radioiodinated and Radiofluorinated Analogues of FT-2102 for SPECT or PET Imaging of mIDH1 Mutant Tumours

    Weber, V., Arnaud, L., Dukic-Stefanovic, S., Wenzel, B., Roux, V., Chezal, J. M., Lai, T. H., & 5 othersTeodoro, R., Kopka, K., Miot-Noirault, E., Deuther-Conrad, W. & Maisonial-Besset, A., 11 Jun 2022, In: Molecules. 27, 12, 3766.

    Research output: Contribution to journal › Research article › Contributed › peer-review

  10. Published

    Palliative care of proximal femur metastatic disease and osteolytic lesions: results following surgical and radiation treatment

    Mehnert, E., Möller, F. S., Hofbauer, C., Weidlich, A., Winkler, D., Troost, E. G. C., Jentsch, C., & 4 othersKamin, K., Mäder, M., Schaser, K. D. & Fritzsche, H., 21 Nov 2024, In: BMC cancer. 24 (2024), 1, 16 p., 1431.

    Research output: Contribution to journal › Research article › Contributed › peer-review

Previous 1...571 572 573 574 575 576 577 578 ...675 Next
Export list (max. 500):